Biopharmaceutical Analysis

The collaboration will see Shimadzu and UMG develop new clinical laboratory methods using LC-MS for TDM analysis.

An orthogonal approach to lipid nanoparticle analysis is recommended to optimize drug development success.

Under this deal, Merck, known as MSD outside of the United States and Canada, will select Veeva products for industry-specific software and data.

A thorough knowledge of both the upstream and downstream processes is required to ensure effective removal of residual impurities in biopharmaceuticals.

Content is king in publishing, but interpretation is imperator.

Using a predictive modeling approach can help tighten up operator control over bioprocessing, which in turn can increase bioreactor output.

OGT has launched the SureSeq Myeloid Plus panel and OGT Universal NGS Complete Workflow.

Using a minimum valuable product and process approach would make it is possible to discipline and structure the development of biopharmaceuticals in the fastest way possible.

Assessment of peripheral blood protein glycosylation has recently become scalable, providing a new domain for biomarker research.

PerkinElmer has unveiled a cell analysis solution to streamline cell and gene therapy research and manufacturing.

A combination of eye imaging techniques and adaptive optics has revealed key details of choroideremia.

The dedicated solid-state research and development suite is designed to promote discovery of novel polymorph, salt, and cocrystal forms.

Using an orthogonal approach to lipid nanoparticle analysis can increase the odds of project success.

A thorough understanding of both regulatory requirements and study challenges can help develop and validate the appropriate methods for a bioanalytical study program.

An early drug candidate screening strategy should incorporate clear targets to lessen late-stage failure.

Avance Clinical’s acquisition of C3 Research Associates expands its CRO services to North America.

Roche’s Digital LightCycler System is designed to aid in diagnostics for cancer, genetic disease, and infection.

A holistic view of the product, manufacturing, and ultimate use of the viral vector is required.

It is important to understand regulatory requirements and study challenges to develop and validate the appropriate methods for a bioanalytical study program at the clinical stage.

CYTENA’s B.SIGHT cell dispenser is designed to streamline single-cell isolation in microbiology research.

The Faustovirus Capping Enzyme launched by New England Biolabs is designed to increase capping efficiency and scalability of mRNA manufacturing workflows.

Guest contributor B.S. Sathya Durga discusses the importance of modernizing India's pharmaceutical manufacturing industry.

Preclinical testing is better able to evaluate complex drug candidates thanks to innovations in animal model approaches.

Synthego has launched new engineered cell libraries to validate targets for quicker drug discovery timelines.

A strong digital backbone is foundational in driving innovation.

Shimadzu’s new ultra-high performance liquid chromatography system is designed to solve common problems in biopharma analysis.

Roche’s new test is the first available immunoassay that allows for simultaneous, independent determination of the hepatitis C virus antigen and antibody status.

The PerkinElmer Flow Cytometry Instrument Concierge Services will provide biopharmaceutical labs with expert, on-site flow cytometry specialists.

Merck, known as MSD outside the United States and Canada, now offers the Merck Digital Sciences Studio, designed to enable innovative tech for drug discovery and development.

Bio-Rad’s CFX Opus Deepwell Real-Time PCR Detection System is designed to support researchers in developing nucleic acid detection assays.